Core Viewpoint - Beijing Sanyuan Foods Co., Ltd. anticipates a significant loss for the fiscal year 2025, primarily due to substantial goodwill impairment related to its investment in the French subsidiary HCo France S.A.S. The projected net profit loss ranges from 356 million to 178 million yuan, with an expected reduction in the investment value of HCo by 496 million to 616 million yuan [1][2]. Group 1: Long-term Equity Investment - The company, in collaboration with Fosun High Technology and Fosun Health, acquired 100% of HCo France through a Luxembourg-based SPV, with the investment value reaching approximately 6.26 billion euros (about 49.32 billion yuan) [2][3]. - The book value of the long-term equity investment in HCo France was reported at 20.59 billion yuan as of June 30, 2025, with previous years showing balances of 17.65 billion yuan and 18.35 billion yuan for 2023 and 2024, respectively [2][3]. Group 2: Financial Performance of HCo France - HCo France reported a net profit of -10,083 million yuan in 2023, primarily due to interest expenses from shareholder loans and bank loans, with a net profit of 14,335 million yuan when excluding these costs [6]. - The projected revenue for HCo France in 2025 is 90,587 million yuan, with an anticipated net loss of -94,453 million yuan, largely attributed to the goodwill impairment of approximately 101,411 million yuan [6][8]. Group 3: Goodwill Impairment Testing - The goodwill impairment testing for 2025 is based on HCo France's management's six-year business plan, which indicates a significant decline in expected future cash flows, leading to a projected impairment of approximately 1.26 billion euros [20][31]. - The testing process revealed that the fair value of HCo France's equity is estimated at 3.89 billion euros, down from a book value of 5.15 billion euros, resulting in a reduction of about 5 billion yuan in the company's investment income for 2025 [20][21]. Group 4: Market Conditions and Strategic Adjustments - The overall market demand for consumer goods has declined, with a reported 3.8% decrease in sales volume in 2025, exacerbated by inflation and competitive pricing pressures [40][41]. - HCo France's management has adjusted its long-term forecasts due to underperformance in strategic initiatives, leading to a more conservative outlook for future growth [43][44].

Core Viewpoint - The company, Sanyuan Foods (三元股份), is expected to report significant losses in 2025 due to impairment provisions related to its investment in the French company HCo, leading to a projected net profit loss of between 178 million to 356 million CNY [1]. Financial Performance - For the fiscal year 2025, the company anticipates a net profit attributable to shareholders of the parent company to be between -376 million to -198 million CNY, excluding non-recurring gains and losses [3]. - After adjusting for the impairment, the expected net profit attributable to shareholders is projected to be between 260 million to 318 million CNY, with a net profit excluding non-recurring items estimated at 240 million to 298 million CNY [3]. - In the same period last year, the company reported a net profit of 54.81 million CNY and a net profit excluding non-recurring items of 29.82 million CNY [3]. - The company expects to achieve an operating revenue of approximately 6.35 billion CNY in 2025, reflecting a year-on-year decline [3]. Investment and Impairment Details - The impairment provision is related to the company's 49% stake in HCo, which acquired StHubert in 2018. The impairment is expected to reduce the book value of long-term equity investments by 496 million to 616 million CNY [4]. - The decline in market demand and increased external competition are cited as factors contributing to the impairment [4]. Recent Performance Metrics - For the first three quarters of 2025, the company reported revenues of 4.871 billion CNY, a year-on-year decrease of 9.7%, while the net profit attributable to shareholders increased by 128.2% to 236 million CNY [4]. - The net profit excluding non-recurring items for the same period rose by 214.5% to 223 million CNY, with a net cash flow from operations of 329 million CNY, up 410.8% [4]. - In Q3 2025, the company achieved revenues of 1.54 billion CNY, a slight decline of 0.3% year-on-year, but turned a profit with a net profit of 53.14 million CNY compared to a loss of 24.77 million CNY in the same quarter last year [5]. Asset and Market Position - As of the end of Q3 2025, the company's total assets amounted to 9.324 billion CNY, a 5.6% increase from the end of the previous year, while the net assets attributable to shareholders grew by 6.0% to 5.238 billion CNY [6]. - As of January 16, 2026, the company's stock price was 5.24 CNY per share, with a total market capitalization of 7.821 billion CNY [7].